Skip to main content
ACS Organic & Inorganic Au logoLink to ACS Organic & Inorganic Au
. 2026 Jun 25;6(4):438–448. doi: 10.1021/acsorginorgau.6c00033

Pursuing the Red-Shift in GlycoporphyrinsA New Synthetic Approach toward Glycoconjugates from the meso-Tetraethynylporphyrin Scaffold

Jakub Mitrzak 1, Maciej Malinowski 1,*
PMCID: PMC13449439  PMID: 42569210

Abstract

Photodynamic therapy is a promising approach to anticancer treatment. For further development of this technique, new photosensitizers that better meet biological criteria are highly desired. Glycoporphyrins are considered more than favorable synthetic targets in this matter. This is due to their increased solubility in aqueous solutions and their targeting ability toward cancer cells. Herein, we report synthetic studies, and we propose an original Sonogashira-based strategy toward unique porphyrin-glycal conjugates. The proposed methodology allowed us to synthesize 5 new examples of photosensitizers in which the sugar unit influenced another crucial factorthe bathochromic shift of the photosensitizer’s absorption profile. These structures were able to absorb wavelengths from the region of 740–780 nm. The studies present the development of a synthetic strategy toward water-soluble glycoporphyrins and the initial recognition of their singlet oxygen production ability.

Keywords: sonogashira reaction, glycals, porphyrin conjugate, glycoporphyrin, photosensitizer(s); ROS, palladium catalysis


graphic file with name gg6c00033_0014.jpg


graphic file with name gg6c00033_0012.jpg

Introduction

Among the family of organic dyes, the porphyrin framework has become one of the most widely explored scaffolds for its biomedical applications, including bioimaging and photoguided therapies like photodynamic inactivation (PDI) and photodynamic therapy (PDT). − The latter is a particularly promising modern approach in anticancer treatment, as it exploits a nontoxic agent (photosensitizer, PS) that, upon light irradiation, produces reactive oxygen species (ROS), which are locally toxic to adjacent cells. As a result, if PS accumulates near cancer cells, their eradication might be achieved with minimal side effects. Regarding the typical properties of porphyrins, they are treated as especially promising scaffolds for the design of new PSs. − They are considered generally biocompatible frameworks, probably due to the omnipresence of this architecture in nature (porphyrin is a framework present in hemes and some chlorophylls). Second, the optical features of these macroheterocycles (absorption of light from the visible region and efficient generation of ROS) naturally predestine them for exploitation in PDT.

Nevertheless, there are still several aspects to be addressed regarding the general application of the porphyrin scaffold in PDT, requiring its functional modifications. , First of all, typical synthetic porphyrins are characterized by low solubility in polar solvents, which significantly reduces their bioavailability. Moreover, it would be of high value if porphyrin were capable of being vectorized toward cancer cells; thus, the selectivity of the whole therapy might be improved. Finally, a bathochromic shift of the absorption maxima would allow us to use lower-energy and more penetrating light doses.

Considering the aforementioned criteria, glycoporphyrins (porphyrin-carbohydrate conjugates) are recognized as prospective candidates for PSs of the third generation. The natural hydrophilic character of sugar moieties provides the amphiphilic nature for the whole system, improving their solubility in polar solvents and bioavailability. − Furthermore, the carbohydrate-recognizing lectins are usually overexpressed in cancer cells, so the sugar unit might play the role of a Trojan horse, providing an improvement in selectivity toward phototherapy targets. −

From the perspective of synthetic studies, glycoporphyrins remain an interesting target, as typical routes toward them usually lead to potentially hydrolyzable C–O or ester bonds, and the literature lacks a more general approach toward these types of frameworks. − Apart from that, among different strategies, click chemistry has offered the concept most suited to be called versatile, and to date, many new examples of carbohydrate-porphyrin hybrids have been synthesized following it. −

In the past few years, our group has introduced an alternative idea in synthetic studies, and we initiated the use of palladium-catalyzed strategies toward C–C bonded glycoconjugates based on the Suzuki-Miyaura reaction or Sonogashira approach. − The main challenge of the catalytic system is to adjust it to efficiently cross-couple two subunits (porphyrin macroheterocycle in reaction with carbohydrate residue) that are so different in terms of chemical origins and chemical properties. In the case of Sonogashira reactivity, despite two theoretical approaches, we have already discovered that the electrophilic partner (halogen atom) should be localized at the macrocycle, while the ethynyl substituent should be a part of the sugar moiety (Scheme A). During these studies, we also found that if the ethynyl fragment is linked to the porphyrin starting material, the Glaser-type side reactivity prevails, leading to undesired oligomerization (Scheme B), and glycoporphyrins were not successfully obtained. Nevertheless, such dendrimerization might be used to its advantage in the construction of glucose colorimetric sensors.

1. State of Art on Sonogashira-type Reactivity towards Glycoporphyrins.

1

In addition to other glycal-porphyrin hybrids, we already demonstrated on porphyrins of A2B2-type that if cross-coupling occurs directly at the meso-position, the sugar residue might participate in the conjugated system, and the red shift (up to 20 nm) of the porphyrin absorption maxima is observed (Scheme C). Therefore, the sugar unit might play an additional beneficial role in the whole photosensitizing system, and this area has not yet been explored in any other glycoporphyrin studies.

Considering these results, we concluded that the full advantage of this phenomenon might be pursued if successful conjugation could be achieved through all of the meso positions on A4-type porphin derivatives. Such red-shifts of Q bands have been reported in some porphin conjugates, − and in the case of porphin derivatives, Sonogashira procedures were introduced with the use of a triphenylarsine ligand to obtain final products in a range of modest to good yields. − Additionally, the Sonogashira-type reactivity was widely applied in the synthesis of molecules for biomedical applications and is generally recognized as a reliable method of porphyrin framework functionalization.

Herein, we present our studies on the synthesis of red-shifted glycoporphyrins from the meso-tetraethynylporphyrin scaffold (Scheme D). Compared with previously described glycoconjugates, − structures presented herein are characterized by the lack of meso-aromatic substituents; therefore, their hydrophobicity is significantly reduced. Following the new method, we obtained 5 original examples of glycoconjugates featuring the bathochromic shift of absorption maxima of up to 40–50 nm.

Results and Discussion

Initial AttemptsApplication of Glycosylated Aldehyde

Regarding the final glycoporphyrin target of our studies, we began with the recognition of the most typical strategy for the synthesis of macroheterocyclic scaffolds. We decided to test the possibility of obtaining propargyl-type glycosylated aldehyde and to use it in the formation of the porphyrin core under Lindsey conditions (Scheme ). That is, this strategy has been somewhat recognized in the case of some carbohydrate-porphyrin hybrids; − however, it has not yet been explored with glycal residues.

2. Concept of Strategy Exploiting the Glycosylation Prior to Porphyrin Core Formation.

2

The introduction of a direct procedure toward 2-iodoglycals has attracted much attention toward them as biologically interesting scaffolds for metal-catalyzed transformations. , With the microwave-assisted improvement in this process, gram-scale amounts of 2-iodoglycals are easily accessible, and we decided to exploit this protocol to our advantage in these studies. As a model glycal substrate, we chose to use 2-iodo-d-glucal derivative 1a as the most convenient in terms of economical availability. Its palladium-catalyzed reactivity has been widely recognized in modern studies, − including methodology of the Sonogashira reaction. ,, Following our previously reported protocol, we introduced a propargyl alcohol moiety, leading to alkyne 2a in a very good yield of 80% (Scheme ). The subsequent oxidation step was tested under 3 typical conditions described for propargyl alcohol moieties. Among PCC, MnO2, or Dess-Martin reagents, the last one was the most optimal to obtain aldehyde 3a (Scheme ).

3. Synthesis of Glycosylated Propargyl Aldehyde 3a .

3

With aldehyde 3a in hand, we screened potential catalyst conditions in Lindsey-type procedures (Scheme ). We quickly excluded BF3•EtO2 from potential catalysts, as even the smallest amounts of it activated side oligomerization reactivity at the glycal moiety. We then focused on an alternative reagent (TFA). However, despite several attempts, we concluded that aldehyde 3a was not an adequate substrate to synthesize porphyrin 4a. Our experiments focused on different concentrations of TFA, but we did not see positive results in the range of 1.7–15.2 mmol/L (Scheme ). The lower concentration did not activate the aldehyde function for nucleophilic attack, and the starting material was recovered. At higher concentrations of TFA, side-reactivity occurred, leading to quick blackening of the reaction mixture without detecting even traces of porphyrin 4a.

4. Attempts on Macrocyclization with the use of Aldehyde 3a .

4

Glycosylation of the Porphyrin Framework

Following the aforementioned results, we alternated the strategy. We decided to synthesize first the macroheterocycle core armed with conjugable, reactive groups and then to glycosylate this porphyrin scaffold. This might be achieved from two variant approaches (Scheme A,B). In both strategies, two glycal starting materials have been well recognized in metal-catalyzed methodologies, and they are rather easily accessible. The major difference is in the availability of the porphyrin scaffold (5a vs 5b, Scheme ), in which alkynylated porphin 5a is directly synthesized from commercially available aldehyde (for the synthesis see SI) unlike tetrabrominated porphin 5b that is obtained through a multistep process with rather low yields. Considering this, we decided to explore only route A in our studies, keeping in mind that suppression of Glaser-type side reactions leading to oligomerization of the macrocycle framework would be the main challenge, as even a singular side process would prevent us from obtaining the final product.

5. Theoretical Approaches to the Same Type of Glycoporphyrins 4 via Sonogashira Reaction.

5

To pursue the goal of our studies, we decided to optimize the Sonogashira procedure between 2-iodoglycal 1a and porphyrin 5a (Scheme ). Starting conditions were selected based on knowledge from previous studies conducted in our group. As the most convenient catalyst, we chose Pd-XPhos-G3, while for the mixture of solvents adequate for both subunits, we decided to use toluene and triethylamine. Finally, we had already observed that oxidative addition of palladium most efficiently occurs with 2-iodoglycals at a temperature of at least 60 °C, so this parameter was kept in current studies as well. ,

6. Model Reaction in Optimization of Sonogashira Approach towards Glycoporphyrin 4a .

6

In very initial experiments toward 4a, we discovered major challenges to overcome in the whole strategy. First of all, the main side-reactivity of porphyrin 5a was its oligomerization, which occurred simultaneously under reaction conditions. Second, we also observed that the highly active catalyst produced from the Buchwald palladium third-generation precatalyst efficiently catalyzes the desired Sonogashira reaction; however, after successful cross-coupling, it is able to launch an unwanted dealkynylation process as well. Thus, some sort of prevention should be applied in our procedure. And last but not least, the overall yield of obtaining 4a describes the yield of 4 subsequent Sonogashira transformations, so every step must be maximally efficient, as even a single unsuccessful reaction prevents from obtaining the final glycoconjugate 4a.

Table describes our route to optimal Sonogashira conditions, leading to 4a. In the starting experiment (Table , entry 1), under conditions inspired from previous studies, we were able to isolate the product 4a in 3% yield, and we also observed significant amounts of insoluble porphyrin oligomers. Interestingly, prolonging the reaction time did not improve the yield (Table , entry 1 vs entry 2); on the contrary, the dealkinylation process prevailed and no glycoconjugate 4a was isolated. This prompted us to test shorter reaction times (Table , entry 1 vs entries 3, 4). Indeed, some improvement was achieved by following this concept. We observed that Sonogashira processes were not fast enough to finish the reaction after 0.5 h (Table , entry 3), although a 2 h reaction was quite a compromise to see high conversion of porphyrin starting material with relatively low side-reactivity, leading to 4a in 13% yield (Table , entry 4). Some enhancement of product formation (Table , entry 5) was also observed with the increase of catalyst loading to 0.3 eq (corresponding to 0.075 eq per reaction center), so this parameter was maintained in further experiments. The screening of the solvent mixture (Table , entry 5 vs entries 6, 7) suggested that toluene is a rather adequate choice in this process. With the higher catalyst loading, we determined that a 1 h reaction is more optimal, and 4a could be isolated with 17% yield (Table , entry 7). Some progress was made when a decrease in catalyst activity was applied by using more equivalents of stabilizing ligand (Table , entry 8). This adjustment allowed us to obtain glycoporphyrin in 21% yield. It also encouraged us to test other catalytic systems (Table , entries 10–13); however, none of the experiments improved the final yields. Probably, harsher conditions are required for efficient oxidative addition of palladium when Pd­(OAc)2 is used in this transformation (Table , entry 10), although not much oligomerization was observed under these conditions. Unlike in the experiment using CuI as a cocatalyst (Table , entry 11), the Glaser-like reactivity was momentous, which prevented us from obtaining any amounts of 4a. This clearly showed us that any amounts of copper are to be excluded from the protocol. Another catalytic system, described for meso-ethynylporphyrin-type starting material, was also not efficient in this transformation (Table , entry 12). An alternative third-generation precatalyst (Pd-BrettPhos-G3, Table , entry 13) showed some positive reactivity (5% yield); however, it was not superior to Pd-XPhos-G3.

1. Optimisation Studies on the Synthesis of Glycoconjugate 4a .

Entry Catalyst (eq) Ligand Solvents (1/1; v/v) Reaction time [h] Porphyrin dosing Overall yield
1. Pd-XPhos-G3 (0.2) XPhos (0.2) Toluene/triethylamine 3 - 3%
2. Pd-XPhos-G3 (0.2) XPhos (0.2) Toluene/triethylamine 18 - 0%
3. Pd-XPhos-G3 (0.2) XPhos (0.2) Toluene/triethylamine 0.5 - 5%
4. Pd-XPhos-G3 (0.2) XPhos (0.2) Toluene/triethylamine 2 - 13%
5. Pd-XPhos-G3 (0.3) XPhos (0.3) Toluene/triethylamine 2 - 16%
6. Pd-XPhos-G3 (0.3) XPhos (0.3) Acetonitrile/triethylamine 2 - 12%
7. Pd-XPhos-G3 (0.3) XPhos (0.3) 1,4-Dioxane/triethylamine 2 - 10%
8. Pd-XPhos-G3 (0.3) XPhos (0.3) Toluene/triethylamine 1 - 17%
9. Pd-XPhos-G3 (0.3) XPhos (0.6) Toluene/triethylamine 1 - 20%
10. Pd(OAc)2 (0.3) XPhos (0.6) Toluene/triethylamine 18 - 0%
11. Pd(OAc)2 (0.2), CuI (0.4 equiv) BrettPhos (0.2) Toluene/triethylamine 1 - 0%
12. Pd2(dba)3 (0.15) AsPh3 (1.6) Toluene/triethylamine 3 - 0%
13. Pd-BrettPhos-G3 (0.3) BrettPhos (0.6) Toluene/triethylamine 1 - 5%
14. Pd-XPhos-G3 (0.3) XPhos (0.6) Toluene/triethylamine 1   12%
15. Pd-XPhos-G3 (0.3) XPhos (0.6) Toluene/triethylamine 1 5a Solid portionwise addition (4 portions, 5 min interval) 26%
16. Pd-XPhos-G3 (0.3) XPhos (0.6) Toluene/triethylamine 1 5a Portionwise injection (14 portions, 3 min interval) 33%
17. Pd-XPhos-G3 (0.3) XPhos (0.6) Toluene/triethylamine 1 5a Continuous injection (20 min) 41%
18. Pd-XPhos-G3 (0.3) XPhos (0.6) Toluene/triethylamine 1 5a Continuous injection (20 min), 5-fold scale reaction 44%
a

General conditions: porphyrin 5a (20 mg, 0.029 mmol, 1.0 equiv), 2-iodoglycal 1a (69 mg, 8.0 equiv), catalyst (0.2–0.3 equiv), ligand (0.2–0.6 equiv), and TBAF·3H2O (37.5 mg, 4.1 equiv), solvent 1 + triethylamine (6 + 6 mL) under an argon atmosphere at 60 °C.

b

Final yield of 4 subsequent reactions, isolated yield of 4a after chromatographic purification.

c

The volume of the solvents increased to 24 mL.

d

Reaction at 70 °C.

At this stage of the optimization, we concluded that the main obstacle in the process was the oligomerization of the porphyrin substrate, and it needs to be suppressed to pursue the studies. Following this concept, we attempted to dilute the reaction mixture; however, it slowed down all of the transformations without increasing the amount of product (Table , entry 9 vs entry 14). Some progress was made after we decided not to add porphyrin alkyne 5a in one portion but to divide it into smaller ones (portionwise addition of solid). By this approach, we kept the high concentration of other reagents while keeping the porphyrin substrate at a lower concentration. This allowed us to increase the yield to 26% (Table , entry 15). Nevertheless, the level of inert atmosphere remained uncertain due to the need for regular opening of the reaction vessel. We improved this approach by using syringe injection of the 5a solution (14 portions) into the reaction mixture. By this strategy, we isolated glycoconjugate 4a in 33% yield (Table , entry 16). However, in this experiment, we observed that if the substrate solution was transferred at room temperature, the solubility of 5a was limited, and significant amounts of porphyrin always remained in the syringe. This prompted us to make a final modification of the reaction protocol. We decided to solubilize 5a at 80 °C and to apply continuous addition of this warm solution through a cannula. This allowed the yield of 4a to improve to 41% (Table , entry 17). Our final experiment was dedicated to increasing the scale of the reaction (5-fold scale). We observed that if the reaction temperature was raised to 70 °C, we were able to better control the proper rate of substrate addition, and this temperature was applied in the final experiment (Table , entry 18). Following this protocol, we isolated the glycoconjugate 4a in a 44% yield, which corresponds to an 81% yield of each Sonogashira step in the whole process. The experiment also confirmed very good scalability of this strategy. These conditions were treated as the optimal ones in further studies.

With optimal conditions in hand, we decided to determine the scope of our methodology. Unlike in our previous studies, the Sonogashira strategy developed herein allows us to apply 2-iodoglycals as sugar synthons. This is particularly convenient, as new routes toward 2-haloglycals are regularly proposed in the current literature and provide access to direct glycosylation protocols of macrocycles. From the perspective of future biological studies, the carbohydrate moieties are important subunits responsible for targeting ability toward cancer cells; thus, diversification of them helps in the adjustment of the PDT selectivity. Lastly, in our previous studies, we already reported that d-galactal residue most significantly influences the red-shifted absorption profile of the glycohybrid, so the sugar unit itself might provide benefits for the photophysical properties of the molecules.

During the scope studies (Scheme ) we exemplified the glycohybrids using monosaccharide glycals of d- and l-series in nearly the same yield: d-galactal moiety (Scheme , 4b, 34%), d-xylal (4c, 37%), and l-rhamnal residue (4d, 40%). For the first time, we were also able to introduce more than one disaccharide-type glycal to glycoporphyrins (d-maltal motif, 4e, 22%), proving the complementary character of this strategy in comparison to our previous methodologies.

7. Scope of the Procedure on Regard to Sugar Motif.

7

The series of glycoporphyrins (4a–e) was then investigated using UV–vis measurements (Figure ). All of the hybrids were characterized by a bathochromic shift of the absorption bands. For the final application, the most interesting region was the Q-band absorption, from the least energetic wavelengths. In the case of all the hybrids, glycoconjugates absorbed light in the biological window region, in the range of 740–780 nm, with absorption maxima at 745–756 nm. It seems that the d-galactal motif adopts the most efficient conformation for conjugation with the macrocycle, and therefore its absorption occurs at the longest wavelengths. The positive impact of our approach is particularly visible when compared with substrate 5a, for which the Q-band appeared at 710 nm (Figure ), while all of the glycoconjugates were bathochromically and hyperchromically shifted.

1.

1

Comparison of the Q bands between glycoporphyrins 4a–e and porphyrin 5a.

For the initial assessment of the photosensitizing abilities of our compounds to produce singlet oxygen, we followed the established UV–vis protocol with 9,10-dimethylanthracene (DMA) used as an indicator. − For the irradiation of 4a–e, we were able to use lower-energy visible light (740 nm lamp), and we monitored the decrease in absorbance of DMA observed at 378 nm. All of the carbohydrate-porphyrin hybrids efficiently generated singlet oxygen, demonstrating their potential for use in PDT (Figure ).

2.

2

Absorbance change of 4a–e solutions with DMA as a function of irradiation time. DMA (300 μM) and 4a-4e (18 μM), λirr = 740 nm photosensitized in DMF.

The procedure of the deprotection step was adjusted from our previous studies and exemplified on the d-glucal derivative (Scheme , 6a). Due to the progressive change in solubility of semideprotected glycoconjugates, we performed the reaction in a two-step process: initially in a mixture of solvents compatible with 4a (DCM:MeOH, 1:1), after 2 h, the solvents were replaced with more compatible ones to solubilize the more polar semideprotected glycoconjugates (acetone:water, 1:1). Following these modifications, we were able to isolate the final glycoporphyrin 6a in a good yield of 67%.

8. Deacetylation Step towards 6a .

8

Apart from the convenient UV–vis profile of 6a, we also considered the benefits of the lack of additional aryl substituents on this type of porphyrin derivative. The parameter of water solubility is still an important matter in current glycoporphyrin studies. These types of structures are often reported as well soluble in aqueous solutions of organic solvents , even in highly diluted water systems. Sole water solubility of sugar-porphyrin hybrids is less frequently reported; however, some polymer sugar conjugates and glycopolymers are characterized by improved solubility in this particular liquid. , To better reflect the affinity of 6a to the water phase, we decided to determine its 1-octanol/water partition coefficient (log P). As reference glycoporphyrins, we decided to use values determined for A2B2-type glycosylated porphyrin (determined for phosphate-buffered saline as the aqueous phase) and A4-type glycoporphyrin with additional meso-aryl substituents (Scheme A). ,

The 1-octanol/water partition coefficient (P o/w) was determined at 25 °C. Po/w values were calculated and expressed in logarithmic form as a ratio of the concentration of 6a in octanol to its concentration in water, using the equation log (P o/w) = log ([6a]o/[6a]w) (Table ). This experiment proved that glycoconjugates directly linked to the porphyrin macrocycle (6a) are more hydrophilic than their counterparts with additional meso-aryl substituents (Table , entries 1,2).

2. 1-Octanol/Water Partition Coefficient of Glycoporphyrins.

glycoporphyrin log (Po/w)
A2B2-types 0.45–0.83
A4-type meso-arylglycoporphyrin 1.43
6a –0.44

The final aspect of our studies was dedicated to the quantification of PS’s ability to generate singlet oxygen. We applied the procedure for ROS quantum yield measurement, which is based on the comparison of the known reference (TPP, 5,10,15,20-tetraphenylporphyrin) , with the value determined for our glycoporphyrins (Figure , Table ). For these studies, we exemplified the results using acetylated glycoporphyrin 4a and its deprotected form (6a). Due to the characteristics of the irradiating lamp (λirr = ± 20 nm), the most reliable results were achieved with the use of the 550 nm lamp (similar, nonzero absorption profile for TPP and 4a, 6a). Both glycoconjugates were characterized with lower quantum yields of ROS than TPP. Probably, the PS with free hydroxyl groups aggregated in the applied solution and/or singlet oxygen is not the main ROS type produced by this compound. Both of these aspects will be carefully evaluated in further biological studies on the application of these compounds in PDT. Nevertheless, the synthetic access to the deprotected glycoporphyrin, in addition to its ability to generate singlet oxygen, makes it an interesting target for challenging these compounds in photomedicine assays.

3.

3

First-order plots for the photooxidation of DMA (300 μM), photosensitized by one of the PS: TPP, 4a, or 6a in DMF; λirr = 550 nm. Values represent ± standard deviation of three separate experiments. Molarities of PS were adjusted to equalize absorption at 550 nm.

3. Kinetic Parameters for the Photooxidation of DMA: Observed Rate Constant (k obs) and Singlet Molecular Oxygen Quantum Yield (ΦΔ ) in DMF.

PS TPP 4a 6a
kobsDMF(s−1)
(1.87 ± 0.21)·10–3 (1.40 ± 0.11)·10–3 (0.37 ± 0.05)·10–3
ΦΔDMF
0.64 0.48 (±0.09) 0.13 (±0.03)

Conclusions

Herein, we propose a new synthetic procedure toward red-shifted glycoporphyrins characterized by significant water solubility. These structures efficiently absorbed light wavelengths from the region of the biological window. The Sonogashira-based strategy allowed us to efficiently cross-couple 2-iodoglycals, including disaccharide-type glycals, with the meso-tetraethynyl porphyrin scaffold. All of the glyconjugates were able to generate singlet oxygen, proving their promising character as candidates for third-generation PSs in photodynamic therapy.

Experimental Methods

General Information

All chemical operations were carried out using sealed tubes or round-bottom flasks. Acetonitrile (POCH) was distilled under argon over CaH2. Triethylamine (Chempur) was dried over KOH. Toluene (Chempur) was dried over molecular sieves (4Å). Other solvents were used without further purification. 1H NMR (600 MHz) and 13C NMR (151 MHz) were recorded at 293 K. Chemical shifts are given in ppm (δ) and are referenced to internal solvent signal or to TMS used as an internal standard. Optical rotations were measured on a polarimeter (Anton-Paar MCP-150) at 598 nm. [α]D20 is expressed in °·cm3·g‑1·dm‑1, and c is expressed in g/100 cm³. High-resolution mass spectra (HRMS, ESI) and mass spectra (MS) were measured on an LTQ Orbitrap Velos spectrometer in positive ionization mode. UV–vis spectra and single-wavelength absorbance measurements for ROS production studies were measured on a VWR UV-6300PC spectrophotometer. IR spectra were measured on a Bruker ALPHA II FT-IR spectrometer with a diamond ATR module. Microwave reactions were conducted in an AntonPaar MonoWave 400 microwave reactor. Reactions were monitored by thin-layer chromatography on silica gel plates (VWR, F254 silica, 200 μm layer thickness, aluminum sheets). Sugar derivatives were spotted by immersing in a 5% ethanolic solution of phosphomolybdic acid followed by heating or rendered under an ultraviolet lamp. Porphyrin derivatives were observed under daylight or rendered under an ultraviolet lamp. All reactions were performed using block heaters unless stated otherwise.

General Procedure for the Glycosylation of Porphyrin 5a

To a sealed tube equipped with a stirring bar, Pd-XPhos-G3 (7.3 mg, 0.009 mmol, 0.3 equiv), XPhos (8.0 mg, 0.018 mmol, 0.6 equiv), TBAF (37.5 mg, 0.118 mmol, 4.1 equiv), and a 2-iodoglycal (0.232 mmol, 8.0 equiv) were added. The reactor was then flushed with argon and sealed with a rubber septum. To a round-bottom flask equipped with a stirring bar, porphyrin 5a (20 mg, 0.029 mmol, 1.0 equiv) was added. The flask was then flushed with argon and sealed with a rubber septum. To the reactor, 2 mL of toluene and 2 mL of triethylamine were added through the rubber septum, and the reactor was heated to 70 °C (or, in some particular procedures, to 60 °C) using a heating mantle. To the flask, 10 mL of toluene and 10 mL of triethylamine were added through the rubber septum, and the flask was heated to 80 °C, also using a heating mantle.

The flask and the reactor were then connected by a cannula, which allowed the transfer of the porphyrin solution to the reactor. The porphyrin solution was added dropwise to the reactor by increasing argon pressure in the flask. The reaction mixture was stirred for 75 min (counted from the moment the addition started; 105 min was applied for 4e). Upon completion, the mixture was filtered through a short pad of Celite and washed with toluene. The filtrate was concentrated in vacuo, and flash chromatography was used to purify the product.

General Procedure for the Estimation of Quantum Yield by 9–10-Dimethylanthracene (DMA)

2.4 μmol of the tested porphyrin was dissolved in 10.0 mL of DMF. For TPP, a similar solution was prepared using 2.4 μmol of porphyrin and 100 mL of DMF. From the prepared solutions, a specific volume was taken and added to the quartz cell to make the final solution’s absorbance equal to 0.05 at 550 nm (0.50 mL for TPP, 0.41 mL for 4a, 0.18 mL for 6a). Next, 1.00 mL of a 0.6 mM solution of DMA in DMF was added to the quartz cell. Lastly, the quartz cell was filled up to 2.0 mL with DMF. The cell’s contents were mixed to ensure a stable absorbance reading.

The test sample was irradiated with an EvoluChem 550 PF lamp (18 W, 550 nm) from a distance of 24 cm. After 30 s of irradiation, the absorbance of the test sample at 377 nm wavelength light was measured using a spectrophotometer. This procedure was then repeated until a total irradiation time of 2.5 was reached. For each porphyrin, 3 tests were performed.

Control samples without a photosensitizer were prepared using 1.00 mL of DMF and 1.00 mL of DMA solution. Blank samples without DMA were prepared by using appropriate volumes of tested porphyrin solutions and then filled up to 2.0 mL with DMF.

Supplementary Material

gg6c00033_si_001.pdf (2.4MB, pdf)

Acknowledgments

Research was funded by National Science Centre (Poland; 2023/51/D/ST5/00384).

Glossary

Abbreviations

DCM

dichloromethane

DMA

9,10-dimethylantracane

DMF

N,N-dimethylformamide

PCC

pyridinium chlorochromate

PDT

photodynamic therapy

PS

photosensitizer

ROS

reactive oxygen species

TFA

trifluoroacetic acid

TPP

5,10,15,20-tetraphenylporphyrin

Data for this article, including original NMR.fid files and UV–vis measurements, are available at Zenodo database [DOI: 10.5281/zenodo.19257685]

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsorginorgau.6c00033.

  • Supporting Information includes experimental procedures, spectroscopic characterization, and copies of NMR and UV/vis spectra ,,,, (PDF)

The manuscript was written through contributions of all authors.

Research was funded by the National Science Centre (Poland) (2023/51/D/ST5/00384).

The authors declare no competing financial interest.

References

  1. Han J., Liu Y., Peng D., Liu J., Wu D.. Biomedical Application of Porphyrin-Based Amphiphiles and Their Self-Assembled Nanomaterials. Bioconjugate Chem. 2023;34(12):2155–2180. doi: 10.1021/acs.bioconjchem.3c00432. [DOI] [PubMed] [Google Scholar]
  2. Simo̅es J. C. S., Sarpaki S., Papadimitroulas P., Therrien B., Loudos G.. Conjugated Photosensitizers for Imaging and PDT in Cancer Research. J. Med. Chem. 2020;63(23):14119–14150. doi: 10.1021/acs.jmedchem.0c00047. [DOI] [PubMed] [Google Scholar]
  3. Glowacka-Sobotta A., Wrotynski M., Kryjewski M., Sobotta L., Mielcarek J.. Porphyrinoids in Photodynamic Diagnosis and Therapy of Oral Diseases. J. Porphyr. Phthalocyanines. 2019;23(1n02):1–10. doi: 10.1142/S108842461850116X. [DOI] [Google Scholar]
  4. Boscencu R., Radulea N., Manda G., Machado I. F., Socoteanu R. P., Lupuliasa D., Burloiu A. M., Mihai D. P., Ferreira L. F. V.. Porphyrin Macrocycles: General Properties and Theranostic Potential. Molecules. 2023;28(3):1149. doi: 10.3390/molecules28031149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kou J., Dou D., Yang L.. Porphyrin Photosensitizers in Photodynamic Therapy and Its Applications. Oncotarget. 2017;8(46):81591–81603. doi: 10.18632/oncotarget.20189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Therapy P., Amos-Tautua B. M., Songca S. P.. Application of Porphyrins in Antibacterial. Molecules. 2019;24:2428–2456. doi: 10.3390/molecules24132456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. O’Connor A. E., Gallagher W. M., Byrne A. T.. Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy. Photochem. Photobiol. 2009;85(5):1053–1074. doi: 10.1111/j.1751-1097.2009.00585.x. [DOI] [PubMed] [Google Scholar]
  8. Oyim J., Omolo C. A., Amuhaya E. K.. Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based Photosensitize Development. Front. Chem. 2021;9(April):1–15. doi: 10.3389/fchem.2021.635344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ghorbani J., Rahban D., Aghamiri S., Teymouri A., Bahador A.. Photosensitizers in Antibacterial Photodynamic Therapy: An Overview. Laser Ther. 2018;27(4):293–302. doi: 10.5978/islsm.27_18-RA-01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mariño-Ocampo N., Dibona-Villanueva L., Escobar-Álvarez E., Guerra-Díaz D., Zúñiga-Núñez D., Fuentealba D., Robinson-Duggon J.. Recent Photosensitizer Developments, Delivery Strategies and Combination-based Approaches for Photodynamic Therapy †. Photochem. Photobiol. 2023;99(2):469–497. doi: 10.1111/php.13749. [DOI] [PubMed] [Google Scholar]
  11. Pham T. C., Nguyen V. N., Choi Y., Lee S., Yoon J.. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy. Chem. Rev. 2021;121(21):13454–13619. doi: 10.1021/acs.chemrev.1c00381. [DOI] [PubMed] [Google Scholar]
  12. Pisarek S., Maximova K., Gryko D.. Strategies toward the Synthesis of Amphiphilic Porphyrins. Tetrahedron. 2014;70(38):6685–6715. doi: 10.1016/j.tet.2014.05.090. [DOI] [Google Scholar]
  13. Pandey V., Raza M. K., Joshi P., Gupta I.. Synthesis of Water-Soluble Thioglycosylated Trans-A2B2Type Porphyrins: Cellular Uptake Studies and Photodynamic Efficiency. J. Org. Chem. 2020;85(10):6309–6322. doi: 10.1021/acs.joc.9b03491. [DOI] [PubMed] [Google Scholar]
  14. Lee J. D. O., Jang D., Hong J. I.. Molecular Recognition of Amino Sugars by a Porphyrin-Based Receptor in Aqueous Media. Bull. Korean Chem. Soc. 2010;31(9):2685–2688. doi: 10.5012/bkcs.2010.31.9.2685. [DOI] [Google Scholar]
  15. Silva S., Pereira P. M. R., Silva P., Almeida Paz F. A., Faustino M. A. F., Cavaleiro J. A. S., Tomé J. P. C.. Porphyrin and Phthalocyanine Glycodendritic Conjugates: Synthesis, Photophysical and Photochemical Properties. Chem. Commun. 2012;48(30):3608–3610. doi: 10.1039/c2cc17561d. [DOI] [PubMed] [Google Scholar]
  16. Ballut S., Naud-Martin D., Loock B., Maillard P.. A Strategy for the Targeting of Photosensitizers. Synthesis, Characterization, and Photobiological Property of Porphyrins Bearing Glycodendrimeric Moieties. J. Org. Chem. 2011;76(7):2010–2028. doi: 10.1021/jo102185d. [DOI] [PubMed] [Google Scholar]
  17. Khan R., Özkan M., Khaligh A., Tuncel D.. Water-Dispersible Glycosylated Poly­(2,5′-Thienylene)­Porphyrin-Based Nanoparticles for Antibacterial Photodynamic Therapy. Photochem. Photobiol. Sci. 2019;18(5):1147–1155. doi: 10.1039/c8pp00470f. [DOI] [PubMed] [Google Scholar]
  18. Lebedeva N. S., Yurina E. S., Guseinov S. S., Gubarev Y. A., Syrbu S. A.. The Interaction of 5,10,15,20-Tetrakis [4- (2,3,4,6-Tetra-O-Acetyl-β-D-Galactopyranosyl) Phenyl] Porphine with Biopolymers. Dye. Pigment. 2019;162(2018):266–271. doi: 10.1016/j.dyepig.2018.10.034. [DOI] [Google Scholar]
  19. Pereira P. M. R., Rizvi W., Bhupathiraju N. V. S. D. K., Berisha N., Fernandes R., Tomé J. P. C., Drain C. M.. Carbon-1 versus Carbon-3 Linkage of d -Galactose to Porphyrins: Synthesis, Uptake, and Photodynamic Efficiency. Bioconjugate Chem. 2018;29(2):306–315. doi: 10.1021/acs.bioconjchem.7b00636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pereira P. M. R., Silva S., Ramalho J. S., Gomes C. M., Girão H., Cavaleiro J. A. S., Ribeiro C. A. F., Tomé J. P. C., Fernandes R.. The Role of Galectin-1 in in Vitro and in Vivo Photodynamic Therapy with a Galactodendritic Porphyrin. Eur. J. Cancer. 2016;68:60–69. doi: 10.1016/j.ejca.2016.08.018. [DOI] [PubMed] [Google Scholar]
  21. Lupu M., Maillard P., Mispelter J., Poyer F., Thomas C. D.. A Glycoporphyrin Story: From Chemistry to PDT Treatment of Cancer Mouse Models. Photochem. Photobiol. Sci. 2018;17(11):1599–1611. doi: 10.1039/c8pp00123e. [DOI] [PubMed] [Google Scholar]
  22. Borzęcka W., Pereira P. M. R., Fernandes R., Trindade T., Torres T., Tomé J. P. C.. Encapsulation of Glycosylated Porphyrins in Silica Nanoparticles to Enhance the Efficacy of Cancer Photodynamic Therapy. Mater. Adv. 2021;2(5):1613–1620. doi: 10.1039/D0MA00830C. [DOI] [Google Scholar]
  23. Daghildjian K., Kasselouri A., N’Diaye M., Michel J.-P., Vergnaud J., Poyer F., Maillard P., Rosilio V.. Mannose Distribution in Glycoconjugated Tetraphenylporphyrins Governs Their Uptake Mechanism and Phototoxicity. J. Porphyr. Phthalocyanines. 2019;23(1n02):175–184. doi: 10.1142/S1088424619500184. [DOI] [Google Scholar]
  24. Chen X., Hui L., Foster D. A., Drain C. M.. Efficient Synthesis and Photodynamic Activity of Porphyrin-Saccharide Conjugates: Targeting and Incapacitating Cancer Cells. Biochemistry. 2004;43(34):10918–10929. doi: 10.1021/bi049272v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fadlan A., Tanimoto H., Ito T., Aritomi Y., Ueno M., Tokuda M., Hirohara S., Obata M., Morimoto T., Kakiuchi K.. Synthesis Photophysical Properties, and Photodynamic Activity of Positional Isomers of TFPP-Glucose Conjugates. Bioorg. Med. Chem. 2018;26(8):1848–1858. doi: 10.1016/j.bmc.2018.02.031. [DOI] [PubMed] [Google Scholar]
  26. Vedachalam S., Choi B. H., Pasunooti K. K., Ching K. M., Lee K., Yoon H. S., Liu X. W.. Glycosylated Porphyrin Derivatives and Their Photodynamic Activity in Cancer Cells. MedChemcomm. 2011;2(5):371–377. doi: 10.1039/c0md00175a. [DOI] [Google Scholar]
  27. Fujimoto K., Miyata T., Aoyama Y.. Saccharide-Directed Cell Recognition and Molecular Delivery Using Macrocyclic Saccharide Clusters: Masking of Hydrophobicity to Enhance the Saccharide Specificity [19] J. Am. Chem. Soc. 2000;122(14):3558–3559. doi: 10.1021/ja993993d. [DOI] [Google Scholar]
  28. Cavaleiro J. A. S., Tomé J. P. C., Faustino M. A. F.. Synthesis Glycoporphyrins. 2007;7:179–248. doi: 10.1007/7081_2007_056. [DOI] [Google Scholar]
  29. Moylan C., Scanlan E., Senge M.. Chemical Synthesis and Medicinal Applications of Glycoporphyrins. Curr. Med. Chem. 2015;22(19):2238–2348. doi: 10.2174/0929867322666150429113104. [DOI] [PubMed] [Google Scholar]
  30. Singh S., Aggarwal A., Bhupathiraju N. V. S. D. K., Arianna G., Tiwari K., Drain C. M.. Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics. Chem. Rev. 2015;115(18):10261–10306. doi: 10.1021/acs.chemrev.5b00244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dixon C. F., Nottingham A. N., Lozano A. F., Sizemore J. A., Russell L. A., Valiton C., Newell K. L., Babin D., Bridges W. T., Parris M. R., Shchirov D. V., Snyder N. L., Ruppel J. V.. Synthesis and Evaluation of Porphyrin Glycoconjugates Varying in Linker Length: Preliminary Effects on the Photodynamic Inactivation OfMycobacterium Smegmatis. RSC Adv. 2021;11(12):7037–7042. doi: 10.1039/D0RA10793J. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hirohara S., Obata M.. Development of Glycoconjugated Photosensitizers for Photodynamic Therapy Using Click Chemistry. J. Japan Soc. Laser Surg. Med. 2023;44(1):30–35. doi: 10.2530/jslsm.jslsm-44_0006. [DOI] [Google Scholar]
  33. Gorczyca K., Kasperski T., Kuklewska A. E., Policht A., Grabowska-Jadach I., Baran D., Jedlińska K., Rowicki T., Strus M., Malinowski M.. Copper-Catalyzed Click-Chemistry Strategy in Synthesis of New Glycoporphyrins – Promising Photosensitizers in Antibacterial Photodynamic Therapy. Eur. J. Med. Chem. 2026;311:118851. doi: 10.1016/j.ejmech.2026.118851. [DOI] [PubMed] [Google Scholar]
  34. Bennion M. C., Burch M. A., Dennis D. G., Lech M. E., Neuhaus K., Fendler N. L., Parris M. R., Cuadra J. E., Dixon C. F., Mukosera G. T., Blauch D. N., Hartmann L., Snyder N. L., Ruppel J. V.. Synthesis of Porphyrin and Bacteriochlorin Glycoconjugates through CuAAC Reaction Tuning. Eur. J. Org. Chem. 2019;2019(38):6496–6503. doi: 10.1002/ejoc.201901128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cecioni S., Matthews S. E., Blanchard H., Praly J. P., Imberty A., Vidal S.. Synthesis of Lactosylated Glycoclusters and Inhibition Studies with Plant and Human Lectins. Carbohydr. Res. 2012;356:132–141. doi: 10.1016/j.carres.2012.02.006. [DOI] [PubMed] [Google Scholar]
  36. Mukosera G. T., Adams T. P., Rothbarth R. F., Langat H., Akanda S., Barkley R. G., Dolewski R. D., Ruppel J. V., Snyder N. L.. Synthesis of Glycosylated Zinc (II) 5,15-Diphenylporphyrin and Zinc (II) 5,10,15,20-Tetraphenylporphyrin Analogs Using Cu-Catalyzed Azide-Alkyne 1,3-Dipolar Cycloaddition Reactions. Tetrahedron Lett. 2015;56(1):73–77. doi: 10.1016/j.tetlet.2014.10.117. [DOI] [Google Scholar]
  37. Daly R., Vaz G., Davies A. M., Senge M. O., Scanlan E. M.. Synthesis and Biological Evaluation of a Library of Glycoporphyrin Compounds. Chem. - A Eur. J. 2012;18(46):14671–14679. doi: 10.1002/chem.201202064. [DOI] [PubMed] [Google Scholar]
  38. Garcia G., Naud-Martin D., Carrez D., Croisy A., Maillard P.. Microwave-Mediated “click-Chemistry” Synthesis of Glycoporphyrin Derivatives and in Vitro Photocytotoxicity for Application in Photodynamic Therapy. Tetrahedron. 2011;67(26):4924–4932. doi: 10.1016/j.tet.2011.04.080. [DOI] [Google Scholar]
  39. Mishra K. B., Tiwari V. K.. Click Chemistry Inspired Synthesis of Morpholine-Fused Triazoles. J. Org. Chem. 2014;79(12):5752–5762. doi: 10.1021/jo500890w. [DOI] [PubMed] [Google Scholar]
  40. Hao E., Jensen T. J., Vicente M. G. H.. Synthesis of Porphyrin-Carbohydrate Conjugates Using “Click” Chemistry and Their Preliminary Evaluation in Human HEp2 Cells. J. Porphyr. Phthalocyanines. 2009;13(1):51–59. doi: 10.1142/S1088424609000085. [DOI] [Google Scholar]
  41. Godlewski B., Malinowski M.. Suzuki-Miyaura Reaction of Glycals with Base-Labile Protecting Groups as a New Route to Glycoporphyrins. Adv. Synth. Catal. 2024;366(13):2956–2966. doi: 10.1002/adsc.202400273. [DOI] [Google Scholar]
  42. Godlewski B., Baran D., de Robichon M., Ferry A., Ostrowski S., Malinowski M.. Sonogashira Cross-Coupling as a Key Step in the Synthesis of New Glycoporphyrins. Org. Chem. Front. 2022;9(9):2396–2404. doi: 10.1039/D1QO01909K. [DOI] [Google Scholar]
  43. Baran D., Malinowski M.. Red-Shifted Glycoporphyrins: Synthesis via Sonogashira Cross-Coupling and Studies on Reactive Oxygen Species Production. Org. Lett. 2025;27(29):7779–7784. doi: 10.1021/acs.orglett.5c02038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Chmielewska H., Baran D., Czerwińska A. M., Godlewski B., Malinowski M., Grabowska-Jadach I.. C-C Conjugated Carbohydrate-Porphyrin Hybrid: Its Therapeutic Potential in Photodynamic Therapy and Cellular Uptake Studies. J. Photochem. Photobiol., B. 2026;280:113472. doi: 10.1016/j.jphotobiol.2026.113472. [DOI] [PubMed] [Google Scholar]
  45. Liu Q., Sun Q., Shen J., Zhang Y., Li H., Yu S., Chen Y., Li X., Jiang J.. A Porphyrin-Based Conjugated Microporous Polymer as a Nanozyme for Glucose Colorimetric Sensing. J. Porphyr. Phthalocyanines. 2023;27(7n10):1119–1125. doi: 10.1142/S1088424623500426. [DOI] [Google Scholar]
  46. Zhang X., Paul-Roth C. O.. New Meso-Tetrafluorenylethynyl Porphyrin Platform. J. Porphyr. Phthalocyanines. 2020;23:185–195. doi: 10.1142/S1088424619500202. [DOI] [Google Scholar]
  47. Wang H., Yue Q., Nakagawa T., Zieleniewska A., Okada H., Ogumi K., Ueno H., Guldi D. M., Zhu X., Matsuo Y.. Star-Shaped Magnesium Tetraethynylporphyrin Bearing Four Peripheral Electron-Accepting Diketopyrrolopyrrole Functionalities for Organic Solar Cells. J. Mater. Chem. A. 2019;7(8):4072–4083. doi: 10.1039/C8TA10710F. [DOI] [Google Scholar]
  48. Ogumi K., Nakagawa T., Okada H., Matsuo Y.. Improved Solubility of Asymmetric Tetraethynylporphyrin Derivatives for Solution-Processed Organic Solar Cells. Org. Electron. 2019;71(February):50–57. doi: 10.1016/j.orgel.2019.04.036. [DOI] [Google Scholar]
  49. Bernardini M. S., Kim J., Kim H., Song M., Jang W. D., Chung D. S., Jung I. H.. Wavelength-Selective Porphyrin Photodiodes via Control of Soret- and Q-Band Absorption. Dye. Pigment. 2021;193(June):109531. doi: 10.1016/j.dyepig.2021.109531. [DOI] [Google Scholar]
  50. Liu Y.-C., Kuo M.-C., Lee C.-W., Liang Y.-R., Lee G.-H., Peng S.-M., Yeh C.-Y.. Synthesis Structure, and Cation Complexation of a Novel Crown Ether Porphyrin. Tetrahedron Lett. 2008;49(50):7223–7226. doi: 10.1016/j.tetlet.2008.10.014. [DOI] [Google Scholar]
  51. Yen W., Lo S. S., Kuo M., Mai C.. Synthesis, Structure, And Optical And Electrochemical Properties Of Star-Shaped Porphyrin – Triarylamine Conjugates. Org. Lett. 2006;8:4239–4242. doi: 10.1021/ol061478w. [DOI] [PubMed] [Google Scholar]
  52. Yan F., Zhang X., Li D., Zhu N., Bao H.. Recent Applications of the Sonogashira Reaction in the Synthesis of Drugs and Their Derivatives: A Review. Appl. Organomet. Chem. 2025;39(1):1–27. doi: 10.1002/aoc.7932. [DOI] [Google Scholar]
  53. Hiroto S., Miyake Y., Shinokubo H.. Synthesis and Functionalization of Porphyrins through Organometallic Methodologies. Chem. Rev. 2017;117(4):2910–3043. doi: 10.1021/acs.chemrev.6b00427. [DOI] [PubMed] [Google Scholar]
  54. Lindsey J. S., Schreiman I. C., Hsu H. C., Kearney P. C., Marguerettaz A. M.. Rothemund and Adler-Longo Reactions Revisited: Synthesis of Tetraphenylporphyrins under Equilibrium Conditions. J. Org. Chem. 1987;52(5):827–836. doi: 10.1021/jo00381a022. [DOI] [Google Scholar]
  55. Štĕpánek P., Dukh M., Aman D., Moravcová J., Kniežo L., Monti D., Venanzi M., Mancini G., Drašar P.. Synthesis and Solvent Driven Self-Aggregation Studies of Meso-“C-Glycoside”-Porphyrin Derivatives. Org. Biomol. Chem. 2007;5(6):960–970. doi: 10.1039/b616096d. [DOI] [PubMed] [Google Scholar]
  56. Casiraghi G., Cornia M., Zanardi F., Rassu G., Ragg E., Bortolini R.. Synthesis and Characterization of Porphyrin-Sugar Carbon Conjugates. J. Org. Chem. 1994;59(7):1801–1808. doi: 10.1021/jo00086a035. [DOI] [Google Scholar]
  57. Cornia M., Valenti C., Capacchi S., Cozzini P.. Synthesis Characterisation and Conformational Studies of Lipophilic, Amphiphilic and Water-Soluble C-Glyco-Conjugated Porphyrins. Tetrahedron. 1998;54(28):8091–8106. doi: 10.1016/S0040-4020(98)00433-5. [DOI] [Google Scholar]
  58. Dharuman S., Vankar Y. D.. N -Halosuccinimide/AgNO3-Efficient Reagent Systems for One-Step Synthesis of 2-Haloglycals from Glycals: Application in the Synthesis of 2C-Branched Sugars via Heck Coupling Reactions. Org. Lett. 2014;16(4):1172–1175. doi: 10.1021/ol500039s. [DOI] [PubMed] [Google Scholar]
  59. Ferry A.. Diversity in Glycochemistry through Metal-Catalyzed Reactions. Comptes Rendus Chim. 2025;28(G1):199–213. doi: 10.5802/crchim.373. [DOI] [Google Scholar]
  60. Hussain N., Ahmed A., Mukherjee D.. 2-Halo Glycals as “Synthon” for 2- C -Branched Sugar: Recent Advances and Applications in Organic Synthesis. Asian J. Org. Chem. 2020;9(6):882–897. doi: 10.1002/ajoc.202000195. [DOI] [Google Scholar]
  61. Baran D., Kuklewska A. E., de Robichon M., Stankiewicz B., Hurej K., Pobudkowska A., Plichta A., Ferry A., Malinowski M.. Rapid Microwave-Assisted Iodination of Glycals to 2-Iodoglycals Under Operationally Simple Conditions: Next Chapter in (C-2)-Functionalisation of Sugar Moieties. Chem.–methods. 2026;6(5):e70113. doi: 10.1002/cmtd.70113. [DOI] [Google Scholar]
  62. Malinowski M., Banoun C., de Robichon M., Lubin-Germain N., Ferry A.. Glycosamine Derivatives through Metal-Catalyzed C–N Bond Formation on Protected and Unprotected 2-Iodoglycals. Eur. J. Org. Chem. 2021;2021(10):1521–1524. doi: 10.1002/ejoc.202001618. [DOI] [Google Scholar]
  63. Monasson O., Malinowski M., Lubin-Germain N., Ferry A.. Hirao Cross-Coupling Reaction as an Efficient Tool to Build Non-Natural C2-Phosphonylated Sugars. Synth. 2022;54(15):3414–3420. doi: 10.1055/a-1709-3305. [DOI] [Google Scholar]
  64. Bordessa A., Ferry A., Lubin-Germain N.. Access to Complex C2-Branched Glycoconjugates via Palladium-Catalyzed Aminocarbonylation Reaction of 2-Iodoglycals. J. Org. Chem. 2016;81(24):12459–12465. doi: 10.1021/acs.joc.6b02278. [DOI] [PubMed] [Google Scholar]
  65. De Robichon M., Bordessa A., Lubin-Germain N., Ferry A.. “cO” as a Carbon Bridge to Build Complex C2-Branched Glycosides Using a Palladium-Catalyzed Carbonylative Suzuki-Miyaura Reaction from 2-Iodoglycals. J. Org. Chem. 2019;84(6):3328–3339. doi: 10.1021/acs.joc.8b03248. [DOI] [PubMed] [Google Scholar]
  66. Malinowski M., Van Tran T., de Robichon M., Lubin-Germain N., Ferry A.. Mild Palladium-Catalyzed Cyanation of Unprotected 2-Iodoglycals in Aqueous Media as Versatile Tool to Access Diverse C2-Glycoanalogues. Adv. Synth. Catal. 2020;362(5):1184–1189. doi: 10.1002/adsc.201901583. [DOI] [Google Scholar]
  67. Darbem M. P., Esteves H. A., Burrow R. A., Soares-Paulino A. A., Pimenta D. C., Stefani H. A.. Synthesis of Unprotected Glyco-Alkynones: Via Molybdenum-Catalyzed Carbonylative Sonogashira Cross-Coupling Reaction. RSC Adv. 2022;12(4):2145–2149. doi: 10.1039/D1RA08388K. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Polák P., Cossy J.. Ni-Catalyzed Cross-Coupling of 2-Iodoglycals and 2-Iodoribals with Grignard Reagents: A Route to 2- C -Glycosides and 2’- C -Nucleosides. Chem. – A Eur. J. 2022;28(27):e202104311. doi: 10.1002/chem.202104311. [DOI] [PubMed] [Google Scholar]
  69. Koester D. C., Werz D. B.. Sonogashira–Hagihara Reactions of Halogenated Glycals. Beilstein J. Org. Chem. 2012;8:675–682. doi: 10.3762/bjoc.8.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Shamim A., Vasconcelos S. N. S., Ali B., Madureira L. S., Zukerman-Schpector J., Stefani H. A.. Ligand and Copper Free Sonogashira Coupling to Achieve 2-Alkynyl d-Glucal Derivatives: Regioselective Electrophile Promoted Nucleophilic 5-Endo-Dig Cyclization. Tetrahedron Lett. 2015;56(43):5836–5842. doi: 10.1016/j.tetlet.2015.08.052. [DOI] [Google Scholar]
  71. Gomes A., Fernandes E., Lima J. L. F. C.. Fluorescence Probes Used for Detection of Reactive Oxygen Species. J. Biochem Biophys. Methods. 2005;65(2–3):45–80. doi: 10.1016/j.jbbm.2005.10.003. [DOI] [PubMed] [Google Scholar]
  72. Sułek A., Pucelik B., Kobielusz M., Barzowska A., Dąbrowski J. M.. Photodynamic Inactivation of Bacteria with Porphyrin Derivatives: Effect of Charge, Lipophilicity, Ros Generation, and Cellular Uptake on Their Biological Activity in Vitro. Int. J. Mol. Sci. 2020;21(22):8716–8734. doi: 10.3390/ijms21228716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sarabando S. N., Dias C. J., Vieira C., Bartolomeu M., Neves M. G. P. M. S., Almeida A., Monteiro C. J. P., Faustino M. A. F.. Sulfonamide Porphyrins as Potent Photosensitizers against Multidrug-Resistant Staphylococcus Aureus (MRSA): The Role of Co-Adjuvants. Molecules. 2023;28(5):2067. doi: 10.3390/molecules28052067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Okada M., Kishibe Y., Ide K., Takahashi T., Hasegawa T.. Convenient Approach to Access Octa-Glycosylated Porphyrins via “Click Chemistry. Int. J. Carbohydr. Chem. 2009;2009:1–9. doi: 10.1155/2009/305276. [DOI] [Google Scholar]
  75. Komano Y., Suzuki M., Matsushita T., Koyama T., Ishimaru Y., Hatano K., Matsuoka K.. Synthesis of Water-Soluble Glycopolymers Bearing Porphyrin by Means of Glycopolymer Assembly and Physical Properties of Glycopolymers Including Ability for Singlet Oxygen Production. Biomacromolecules. 2025;26(5):3021–3031. doi: 10.1021/acs.biomac.5c00121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Ishimaru Y., Moteki T., Suzuki M., Koyama T., Matsushita T., Hatano K., Matsuoka K.. Preparation of a Water-Soluble Glycopolymer Bearing Porphyrin Skeletons and Its Biological Properties. ACS Omega. 2023;8(40):37451–37460. doi: 10.1021/acsomega.3c05581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Ballatore M. B., Spesia M. B., Milanesio M. E., Durantini E. N.. Synthesis Spectroscopic Properties and Photodynamic Activity of Porphyrin-Fullerene C60 Dyads with Application in the Photodynamic Inactivation of Staphylococcus Aureus. Eur. J. Med. Chem. 2014;83:685–694. doi: 10.1016/j.ejmech.2014.06.077. [DOI] [PubMed] [Google Scholar]
  78. Mora S. J., Milanesio M. E., Durantini E. N.. Spectroscopic and Photodynamic Properties of 5,10,15, 20-Tetrakis­[4-(3-n,n- Dimethylaminopropoxy)­Phenyl]­Porphyrin and Its Tetracationic Derivative in Different Media. J. Photochem. Photobiol., A. 2013;270:75–84. doi: 10.1016/j.jphotochem.2013.07.013. [DOI] [Google Scholar]
  79. Bhaumik J., Weissleder R., McCarthy J. R.. Synthesis and Photophysical Properties of Sulfonamidophenyl Porphyrins as Models for Activatable Photosensitizers. J. Org. Chem. 2009;74(16):5894–5901. doi: 10.1021/jo900832y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Liu B., Liu D., Rong X., Lu X., Fu Y., Liu Q.. Ligand-Controlled Stereoselective Synthesis of 2-Deoxy-β-C-Glycosides by Cobalt Catalysis. Angew. Chem., Int. Ed. 2023;62(22):e202218544. doi: 10.1002/anie.202218544. [DOI] [PubMed] [Google Scholar]
  81. Anderson H. L.. Meso-Alkynyl Porphyrins. Tetrahedron Lett. 1992;33(8):1101–1104. doi: 10.1016/S0040-4039(00)91871-9. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

gg6c00033_si_001.pdf (2.4MB, pdf)

Data Availability Statement

Data for this article, including original NMR.fid files and UV–vis measurements, are available at Zenodo database [DOI: 10.5281/zenodo.19257685]


Articles from ACS Organic & Inorganic Au are provided here courtesy of American Chemical Society

RESOURCES